Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Title||Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) (QuANTUM-First)|
|Recruitment||Active, not recruiting|
|Sponsors||Daiichi Sankyo Inc.|
|Age Groups:||senior | adult|
|Covered Countries||USA | ITA | FRA | ESP | DEU | CAN | BEL|